Solanbridge Group, Inc.
Solanbridge Group, Inc. (SLNX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SLNX · as of Jun 9, 2026
Key Statistics
Explore Solanbridge Group, Inc. Data
slnx stock data · financialsAbout Solanbridge Group, Inc.
Solanbridge Group, Inc. concentrates its efforts on cultivating and marketing medical cannabis in Nova Scotia, Canada. Additionally, the organization is committed to developing and distributing a rang…
what is solanbridge group, inc. · slnx stock overview · solanbridge group, inc. company profile · who is solanbridge group, inc. ceo · slnx OTC · solanbridge group, inc. headquarters · solanbridge group, inc. business segments
About Stock Overview & Key Data
Solanbridge Group, Inc. (SLNX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jun 29, 2007. As of the latest trading session, SLNX stock price is $0.00, with a market capitalization of $476,000. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Solanbridge Group, Inc. (SLNX) stock price is $0.00. The stock is traded on OTC under the ticker symbol SLNX. The 52-week range is $0.00 – $0.00.